Bruker Announces New D6 PHASERTM Benchtop X-Ray Diffraction (XRD) Platform for Materials Analysis and Advanced Research
27 Junho 2023 - 11:00AM
Business Wire
Bruker Corporation (Nasdaq: BRKR), the global leader in X-ray
diffraction, today announces the new D6 PHASERTM X-Ray
Diffraction (XRD) system. The D6 PHASER is a new benchtop XRD
platform designed with the analytical flexibility typically
only available in larger, floor-standing systems. Unlike
conventional, more limited benchtop XRD instruments, the D6
PHASER enables analytical methods that go beyond powder
diffraction. With its wide range of capabilities, the D6 PHASER
will enable more XRD applications for new markets and user
communities.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230627894232/en/
D6 PHASER – the versatile new benchtop
XRD platform (Photo: Business Wire)
Building on the success of the D2 PHASER, the D6 PHASER
combines the functionality of the floor-standing D8 platform with
an innovative benchtop design that includes high X-ray excitation
power and a versatile set of X-ray optics. The Motorized Air
Scatter Screen (MASS) enables Dynamic Beam Optimization
(DBO) for optimum performance over the goniometer range. The D6
PHASER can be equipped with a range of sample stages for a large
variety of X-ray diffraction applications, including capillary
transmission, grazing incidence diffraction, X-ray reflectometry,
residual stress, texture analysis, and non-ambient investigations.
The DaVinci stage-interface allows swapping sample stages
without realignment.
The patented D6 PHASER goniometer provides intrinsic angular
accuracy of ≤0.01° over the 2θ range.
With a touch on the integrated panel, the D6 PHASER automatically
performs verification of angular accuracy. The D6 PHASER
offers the family of LYNXEYETM detectors. For the analysis
of non-perfect powder samples, the user can select the patented
Bragg2DTM method. The optional LYNXEYE XE-T detector offers
proprietary suppression of Cu-Kß reflections without the usual
constraints when using a Kß metal filter.
The versatile D6 PHASER combined with
DIFFRAC.SUITETM software provides flexibility for automated
push-button methods or to customize measurement configurations for
optimized data quality. The D6 PHASER needs no external
water cooling and has no special electrical requirements for
convenience to bring versatile, high-performance XRD to any
laboratory. Finally, the D6 PHASER complies with the latest
radiation protection and machinery directives, and it is available
as a GxP compliant solution.
Dr. Frank Burgaezy, President of the Bruker AXS Division,
commented: “Offering unmatched benchtop capabilities, versatility,
and a great user experience, the D6 PHASER is an innovative
benchtop X-ray diffraction platform to help users answer today’s
materials analysis questions and support tomorrow’s advanced
materials discoveries.”
The D6 PHASER makes advanced XRD methods accessible for applied
markets like clean energy.
Dr. Jan Vos, Researcher at Magneto Special Anodes stated: “We
are heavily invested in the development of electrocatalytic
coatings that will form the beating heart of the next generation of
water electrolyzers in the green energy transition. Bruker's new D6
PHASER platform will provide us with the extraordinary power,
flexibility, and accuracy needed to push our coating development
forward. We will have access to advanced X-ray techniques crucial
for material science that were previously not available in a
compact benchtop system. We are looking forward to creating a big
push on the market, and the D6 PHASER will no doubt aid us greatly
in making this possible.”
For more information about the D6 PHASER, please visit
www.bruker.com/d6phaser.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high performance scientific instruments and high
value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular, and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity, and customer success in life
science molecular and cell biology research, in applied and pharma
applications, in microscopy and nanoanalysis, as well as in
industrial applications. Bruker offers differentiated, high-value
life science and diagnostics systems and solutions in preclinical
imaging, clinical phenomics research, proteomics and multiomics,
spatial and single-cell biology, functional structural and
condensate biology, as well as in clinical microbiology and
molecular diagnostics. Please visit www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230627894232/en/
Media Contact: Dr. Heiko Ress Bruker AXS Director
Marketing Communications T: +(49) 721 50997-0 E:
heiko.ress@bruker.com
Investor Relations Contact: Justin Ward Sr. Director
Investor Relations & Corp Development T: +1 (978) 313-5800 E:
Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Bruker (NASDAQ:BRKR)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024